AKR1B1, a member of the aldo/keto reductase superfamily, was associated with the poor survival outcomes of basal-like breast cancer and can promote the occurrence and metastasis of cancer by activating epithelial-mesenchymal transition [26]. Here, AKR1B1 is linked to breast carcinoma.